Surgery can come with risks like bleeding, infection, and blood clots, and it isn't for everyone
This article examines the mechanisms, clinical implications, management strategies, and situations requiring medical consultation related to GLP-1-induced delayed gastric emptying
Materials and methods Study design We propose an open-label, parallel-arm, randomized controlled trial designed to evaluate the impact of semaglutide discontinuation strategies on weight and cardiometabolic outcomes
The reality is that that what the FDA means by safety is a matter of regulatory compliance (large scale clinical trials, manufacturing standards, etc.) not toxicity
CREDENCE enrolled patients with established diabetic kidney diseasepatients who we see filling our CKD clinics and, unfortunately, filling our dialysis units (Figures 5 and 6)
Conclusion: Which medication is right for you